Memantine as an Augmentation Therapy for Anxiety Disorders
Objective. Glutamate, an excitatory neurotransmitter in the central nervous system (CNS), may play a role in the development of anxiety. Memantine partially blocks N-methyl-D-aspartate (NMDA) receptors' glutamate channels located in the CNS. This paper evaluates memantine as an augmentation the...
Saved in:
| Main Authors: | Thomas L. Schwartz, Umar A. Siddiqui, Shafi Raza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2012/749796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioequivalence study drug containing memantine
by: A. A. Karlitskaya, et al.
Published: (2013-09-01) -
An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder
by: Sriram Ramaswamy, et al.
Published: (2015-01-01) -
The Evaluation of Memantine Effect on Tinnitus Severity
by: Babak Pourayyoubi, et al.
Published: (2025-07-01) -
Memantine in Psychiatry: An Underutilized Therapeutic Breakthrough?
by: Harsimar Kaur, et al.
Published: (2025-06-01) -
Tackling Negative Symptoms of Schizophrenia with Memantine
by: Antonios Paraschakis
Published: (2014-01-01)